Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC27A4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HSPA14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRKD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC12A8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC102724984 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ST6GALNAC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MESDC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERLEC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTMR12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAGEF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCNJ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GMDS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THYN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TGFA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLRX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPIL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIMP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on